Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours Β· Estimated delivery Aug 14 - Aug 19
TB-500 and Thymosin Beta-4 are also prohibited by WADA/USADA under S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics), applicable at all times both in-competition and out-of-competition TB-500 / Thymosin Beta-4 Clinical Trials: The RGN-352 and RGN-259 Programs RegeneRx Biopharmaceuticals has pursued two clinical development programs for Thymosin Beta-4, providing the most substantial human clinical data available for any TB-500-related compound: RGN-352 (Injectable Thymosin Beta-4 for Cardiac Repair): Phase 1 trial (completed): A double-blind, placebo-controlled study enrolled 40 healthy volunteers across four cohorts of 10 subjects each, testing escalating dose levels of intravenous Thymosin Beta-4 administered daily over 14 days
Despite these promising findings, significant challenges remain in translating NDBs into clinical applications
We use cyanocobalamin , the form of vitamin B12 with the longest clinical history, the most extensive research backing its safety, and the consistent potency required for repeated treatments
Patt, L
US$ 25.83
US$ 21.32
US$ 24.25
US$ 24.30
US$ 29.02
US$ 28.94
US$ 26.73
US$ 29.33
US$ 29.72
US$ 23.16
